SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 142 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 11.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $85,223 | +27.4% | 88,774 | -0.5% | 0.00% | – |
| Q1 2023 | $66,918 | +96.8% | 89,224 | -3.0% | 0.00% | – |
| Q4 2022 | $34,000 | +88.9% | 91,972 | +121.1% | 0.00% | – |
| Q3 2022 | $18,000 | -14.3% | 41,596 | +50.2% | 0.00% | – |
| Q2 2022 | $21,000 | -95.8% | 27,701 | -26.5% | 0.00% | -100.0% |
| Q1 2022 | $504,000 | +1192.3% | 37,708 | +24.1% | 0.00% | – |
| Q4 2021 | $39,000 | -42.6% | 30,382 | -3.6% | 0.00% | – |
| Q3 2021 | $68,000 | -57.2% | 31,503 | -26.0% | 0.00% | – |
| Q2 2021 | $159,000 | +127.1% | 42,559 | +101.9% | 0.00% | – |
| Q1 2021 | $70,000 | -10.3% | 21,077 | -7.9% | 0.00% | – |
| Q4 2020 | $78,000 | +2.6% | 22,880 | +23.5% | 0.00% | – |
| Q3 2020 | $76,000 | +261.9% | 18,528 | +195.8% | 0.00% | – |
| Q2 2020 | $21,000 | -78.4% | 6,264 | -85.1% | 0.00% | – |
| Q1 2020 | $97,000 | – | 42,017 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |